期刊文献+

卵巢上皮性癌患者预后列线图预测模型的建立与应用 被引量:11

Establishment and application of a nomogram model for prognostic risk prediction in patients with epithelial ovarian cancer
原文传递
导出
摘要 目的:探讨影响卵巢上皮性癌(卵巢癌)患者预后的相关因素,构建列线图预测模型,对卵巢癌患者的预后进行评估。方法:回顾性分析2016年8月11日至2018年7月11日在陆军军医大学第一附属医院进行初始治疗的208例卵巢癌患者的临床病理资料,包括年龄、术前有无腹水、有无新辅助化疗、手术方式、病理类型、病理分化程度、手术病理分期以及术前和化疗后血清癌相关抗原125(CA 125)水平、人附睾蛋白4(HE4)水平、血小板计数、血小板计数/淋巴细胞计数比值(PLR)。对影响卵巢癌患者无进展生存时间(PFS)的相关因素进行单因素和多因素Cox比例风险模型分析,并以此建立卵巢癌患者PFS的列线图预测模型,评估其预测卵巢癌患者PFS的效能。 结果:单因素分析显示,有无新辅助化疗、病理类型、病理分化程度、手术病理分期以及术前和化疗后血清CA 125、HE4水平、血小板计数、PLR均与卵巢癌患者PFS预后显著相关( P均<0.05);多因素分析显示,手术病理分期、术前PLR、化疗后血清CA 125水平、化疗后血清HE4水平均为影响卵巢癌患者PFS的独立因素( P均<0.01),以此建立的卵巢癌患者预后的列线图预测模型的一致性系数为0.749(95% CI为0.699~0.798),该模型具有显著的预测效能。 结论:基于手术病理分期、术前PLR、化疗后血清CA 125水平和化疗后血清HE4水平这4个临床病理指标构建的列线图预测模型,有效预测卵巢癌患者初始治疗后的无进展生存情况,可帮助临床医师筛查高危患者并提供个体化治疗,以改善卵巢癌患者的预后。 Objective To explore the prognostic factors of epithelial ovarian carcinoma(EOC),construct a nomogram model,and evaluate the prognosis of EOC patients.Methods A retrospective analysis was performed on clinicopathological data of 208 cases of EOC patients who received initial treatment in the First Affiliated Hospital of Army Medical University from August 11,2016 to July 11,2018,including age,preoperative ascites,preoperative neoadjuvant chemotherapy,surgical method,pathological type,pathological differentiation degree,surgical pathology stage,preoperative and post-chemotherapy serum cancer antigen 125(CA125)level,human epididymal protein 4(HE4)level,platelet count and platelet/lymphocyte number ratio(PLR).The univariate and multivariate Cox risk ratio models were used to analyze the related factors affecting progression free survival(PFS)in EOC patients,and the prediction nomogram of PFS in EOC patients was established to evaluate its efficacy in predicting PFS.Results Univariate analysis showed that preoperative neoadjuvant chemotherapy,pathological type,pathological differentiation degree,surgical pathology stage,serum CA125 and HE4 level before operation and after chemotherapy,platelet count and PLR before operation and after chemotherapy were significantly correlated with PFS in EOC patients(all P<0.05).Multivariate analysis showed that surgical pathology stage,preoperative PLR,serum CA125 and HE4 level after chemotherapy were independent prognostic factors affecting PFS of EOC patients(all P<0.01).The index coefficient of the prediction model for the prognosis of EOC patients established by this method was 0.749(95%CI:0.699-0.798),which had good prediction ability,and could help clinicians to more accurately evaluate the prognosis of EOC patients.Conclusion The nomogram model constructed based on surgical pathology stage,preoperative PLR,serum CA125 and HE4 level after chemotherapy could effectively predict the PFS of EOC patients after initial treatment,could help clinicians to screen high-risk patients,provide individualized treatment,and improve the prognosis of EOC patients.
作者 李真 蔡雄伟 阎萍 周丹 何明敏 邓黎 王延洲 梁志清 Li Zhen;Cai Xiongwei;Yan Ping;Zhou Dan;He Mingmin;Deng Li;Wang Yanzhou;Liang Zhiqing(Department of Obstetrics and Gynecology,the First Affiliated Hospital of Army Medical University,Chongqing 400038,China)
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2022年第3期190-197,共8页 Chinese Journal of Obstetrics and Gynecology
基金 重庆市社会民生科技创新专项基金(cstc2015shmszx10023)。
关键词 卵巢肿瘤 卵巢上皮癌 列线图 预后 预测 比例危险度模型 回顾性研究 Ovarian neoplasms Carcinoma,ovarian epithelial Nomograms Prognosis Forecasting Proportional hazards models Retrospective studies
  • 相关文献

参考文献5

  • 1H.Agakishiev,M.M.Aggarwal,Z.Ahammed,A.V.Alakhverdyants,I.Alekseev,J.Alford,B.D.Anderson,C.D.Anson,D.Arkhipkin,G.S.Averichev,J.Balewski,D.R.Beavis,N.K.Behera,R.Bellwied,M.J.Betancourt,R.R.Betts,A.Bhasin,A.K.Bhat,H.Bichsel,J.Bieleik,J.Bielcikova,B.Biritz,L.C.Bland,W.Borowski,J.Bouchet,E.Braidot,A.V.Brandin,A.Bridgeman,S.G.Brovko,E.Bruna,S.Bueltmann,I.Bunzarov,T.P.Burton,X.Z.Cai,H.Caines,M.Calderon de la Barca Sanchez,D.Cebra,R.Cendejas,M.C.Cervantes,Z.Chajecki,P.Chaloupka,S.Chattopadhyay,H.F.Chen,J.H.Chen,J.Y.Chen,L.Chen,J.Cheng,M.Cherney,A.Chikanian,K.E.Choi,W.Christie,P.Chung,M.J.M.Codrington,R.Corliss,J.G.Cramer,H.J.Crawford,S.Dash,A.Davila Leyva,L.C.De Silvat,R.R.Debbe,T.G.Dedovich,A.A.Derevschikov,R.Derradi de Souza,L.Didenko,P.Djawotho,S.M.Dogra,X.Dong,J.L.Drachenberg,J.E.Draper,J.C.Dunlop,L.G Efimov,M.Elnim,J.Engelage,G Eppley,M.Estienne,L.Eun,O.Evdokimov,R.Fatemi,J.Fedorisin,A.Feng,R.G.Fersch,P.Filip,E.Finch,V.Fine,Y.Fisyak,C.A.Gagliardi,D.R.Gangadharan,A.Geromitsos,F.Geurts,P.Ghosh,Y.N.Gorbunov,A.Gordon,O.Grebenyuk,D.Grosnick,S.M.Guertin,A.Gupta,W.Guryn,B.Haag,O.Hajkova,A.Hamed,L-X.Han,J.W.Harris,J.P.Hays-Wehle,M.Heinz,S.Heppelmann,A.Hirsch,E.Hjort,G.W.Hoffmann,D.J.Hofiman,B.Huang,H.Z.Huang,T.J.Humanic,L.Huo,G.Igo,P.Jacobs,W.W.Jacobs,C.Jena,F.Jin,J.Joseph,E.G.Judd,S.Kabana,K.Kang,J.Kapitan,K.Kauder,H.Ke,D.Keane,A.Kechechyan,D.Kettler,D.P.Kikola,J.Kiryluk,A.Kisiel,V.Kizka,A.G.Knospe,D.D.Koetke,T.Kollegger,J.Konzer,I.Koralt,L.Koroleva,W.Korsch,L.Kotchenda,V.Kouchpil,P.Kravtsov,K.Krueger,M.Krus,L.Kumar,P.Kurnadi,M.A.C.Lamont,J.M.Landgraf,S.LaPointe,J.Lauret,A.Lebedev,R.Lednicky,J.H.Lee,W.Leight,M.J.LeVine,C.Lil,L.Li,N.Li,W.Li,X.Li,X.Li,Y.Li,Z.M.Li,M.A.Lisa,F.Liu,H.Liu,J.Liu,T.Ljubicic,W.J.Llope,R.S.Longacre,W.A.Love,Y.Lu,E.V.Lukashov,X.Luo,G.L.Ma,Y.G.Mai,D.P.Mahapatra,R.Majka,O.I.Mall,L.K.Mangotra,R.Manweiler,S.Margetis,C.Markert,H.Masui,H.S.Matis,Yu.A.Matulenko,D.MeDonald,T.S.McShane,A.Meschanin,R.Milner,N.G.Minaev,S.Mioduszewski,A.Mischke,M.K.Mitrovski,B.Mohanty,M.M.Mondal,B.Morozov,D.A.Morozov,M.G.Munhoz,M.Naglis,B.K.Nandi,T.K.Nayak,P.K.Netrakanti,L.V.Nogach,S.B.Nurushev,G.Odyniec,A.Ogawa,Oh,Ohlson,V.Okorokov,E.W.Oldag,D.Olsont,M.Pachr,B.S.Page,S.K.Pal,Y.Pandit,Y.Panebratsev,T.Pawlak,H.Pei,T.Peitzmann,C.Perkins,W.Peryt,S.C.Phatak,P.Pile,M.Planinic,M.A.Ploskon,J.Pluta,D.Plyku,N.Poljak,A.M.Poskanzer,B.V.K.S.Potukuchi,C.B.Powell,D.Prindle,N.K.Pruthi,A.M.Poskanzer,B.V.K.S.Potukuchi,B.Powell,D.Prindle,N.K.Pruthi,P.R.Pujahar,J.Putschke,H.Qiu,R.Raniwala,S.Raniwala,R.L.Ray,R.Redwine,R.Reed,H.G.Riter,J.B.Roberts,O.V.Rogachevskiy,J.L.Romero,A.Rose,L.Ruan,J.Rusnak,N.R.Sahoo,S.Sakai,I.Sakrejda,T.Sakuma,S.Salur,J.Sandweiss,E.Sangaline,A.Sarkar,J.Schambach,R.P.Scharenberg,A.M.Schmah,N.Schmitz,T.R.Schuster,J.Seele,J.Seger,I.Selyuzhenkov,P.Seyboth,E.Shahaliev,M.Shao,M.Sharma,S.S.Shi,Q.Y.Shou,E.P.Sichtermann,F.Simon,R.N.Singaraju,M.J.Skoby,N.Smirnov,H.M.Spinka,B.Srivastava,T.D.S.Stanislaus,D.Staszak,S.G.Steadman,J.R.Stevens,R.Stock,M.Strikhanov,B.Stringfellow,A.A.P.Suaide,M.C.Suarez,N.L.Subba,M.Sumbera,X.M.Sun,Y.Sun,Z.Sun,B.Surrow,D.N.Svirida,T.J.M.Symons,A.Szanto de Toledo,J.Takahashi,A.H.Tang,Z.Tang,L.H.Tarini,T.Tarnowsky,D.Thein,J.H.Thomas,J.Tian,A.R.Timmins,D.Tlusty,M.Tokarev,V.N.Tram,S.Trentalange,R.E.Tribble,Tribedy,O.D.Tsai,T.Ullrich,D.G.Underwood,G.Van Buren,G.van Nieuwenhuizen,J.A.Vanfossen,R.Varma,G.M.S.Vasconcelos,A.N.Vasiliev,F.Videbaek,Y.P.Viyogi,S.Vokal,M.Wadat,M.Walker,F.Wang,G.Wang,H.Wang,J.S.Wang,Q.Wang,X.L.Wang,Y.Wang,G.Webb,J.C.Webb,G.D.Westfall,C.Whitten,H.Wieman,S.W.Wissink,R.Witt,W.Witzke,Y.F.Wu,Xiao,W.Xie,H.Xu,N.Xu,Q.H.Xu,W.Xu,Y.Xu,Z.Xu,L.Xue,Y.Yang,P.Yepes,K.Yip,I-K.Yoo,M.Zawisza,H.Zbroszczyk,W.Zhan,J.B.Zhang,S.Zhang,W.M.Zhang,X.P.Zhang,Y.Zhang,Z.P.Zhang,J.Zhao,C.Zhong,W.Zhou,X.Zhu,Y.H.Zhu,R.Zoulkarneev,Y.Zoulkarneeva.Measurements of dihadron correlations relative to the event plane in Au+Au collisions at√^(S)NN=200 GeV[J].Chinese Physics C,2021,45(4):198-241. 被引量:351
  • 2Fang-Ze Wei,Shi-Wen Mei,Jia-Nan Chen,Zhi-Jie Wang,Hai-Yu Shen,Juan Li,Fu-Qiang Zhao,Zheng Liu,Qian Liu.Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy[J].World Journal of Gastroenterology,2020,26(42):6638-6657. 被引量:5
  • 3刘媛媛,李力.浆液性卵巢癌治疗后远期生存列线图预测模型的构建和验证[J].现代妇产科进展,2022,31(2):107-112. 被引量:3
  • 4李希,林敏,马犇,顾正田,康佳丽.治疗前炎症指标构建模型预测卵巢癌患者术后生存[J].中山大学学报(医学科学版),2021,42(6):937-943. 被引量:5
  • 5郭秀红,张文琪,高建楠.术前外周血血小板/淋巴细胞比值对卵巢癌患者预后的影响[J].医学与哲学(B),2015,36(7):57-59. 被引量:3

二级参考文献19

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012[J]. CA Cancer J Clin,2012,62(1) :10-29.
  • 2Unal D, Eroglu C, Kurtul N, et al. Are neutrophil/lymphocyte and platelet/lymphoeyte rates in patients with non-small cell long canc- er associated with treatment response and prognosis[-J:. Asian Pac J Cancer Prev,2013,14(9) :5237-5242.
  • 3Kilincalp S, Cobans, Akinci H, et al. Neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and mean platelet volume as potential biomar kers for early detection and monitoring of colorectal adenocarcinoma[J]. Eur J Cancer Prey,2015,24(4):328-333.
  • 4Jaiswal M,Larusso N F,Gores G J. Nitric oxide in gastrointestinal epi- thelial cell earcinogenesisdinking inflammation to oncogenesis[J]. Am J Physiol Gastrointest Liver Physiol, 2001,281 (3) : 626 - 634.
  • 5Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow [J].Lancet,2001,357(9276):539-545.
  • 6Proctor M J, Morrison D S, Talwar D,et al. A comparison of in- flammation-based prognostic scores in patients with cancer. A Glas- gow Inflammation Outcome Study[J]. Eur J Cancer, 2011,47 (17): 2633-2641.
  • 7Suh D H,Kim H S,Chung H H,et al. Pre-operative systemic in- flammatory response markers in predicting lymph node metastasis in endometrioid endometrial adenocarcinoma[J]. Nut J Obstet Gy- necol Reprod Biol,2012,162(2) :206-210.
  • 8Lee Y Y, Choi C H, Kim H J, et al. Pretreatment neutrophil: lym- phocyte ratio as a prognostic factor in cervical carcinoma[J]. Anti- cancer Res, 2012,32(4) : 1555- 1561.
  • 9Crasta J A,Premlatha T S,Krishnan S M,et al. Significance of pre- operative thrombocytosis in epithelial ovarian cancer[J]. Indian J Pathol Microhiol, 2010,53 (1) : 54- 56.
  • 10Yildirim M A, Seckin K D, Togrul C, et al. Roles of Neutrophil/Lymphocyte and Platelet/Lymphocyte Ratios in the Early Diagnosis of Malignant Ovarian Masses[J]. Asian Pac J Cancer Prey, 2014,15 (16) :6881-6885.

共引文献362

同被引文献136

引证文献11

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部